AxoGen Reports Mixed Q2 Results; Updates FY26 Outlook
AxoGen (AXGN) reported mixed financial results for the second quarter of fiscal year 2026. While revenue grew to $69.7 million, a 23% increase from the prior year and ahead of expectations by $2.6 million, the company posted a non-GAAP EPS loss of -$0.12 per share, missing estimates by $0.24. Adjusted EBITDA for Q2 was reported at $8.4 million, down slightly compared to $9.3 million in the same period last year. The mixed performance prompted AxoGen to update its full-year 2026 outlook, reflecting ongoing challenges despite strong revenue growth. The company remains focused on long-term strategic goals but faces near-term financial pressures that could affect investor sentiment and market confidence.
Tickers: $AXGN
Topics: Earnings EPS Miss Revenue Beat